Doctor of Dentistry Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Marny Lemons-Prince

Dentist, Periodontics Little Rock, AR Doctor of Dentistry

NPI 1134134703 CMS profile 50820

1225 Breckenridge Dr, Suite 210, Little Rock, AR 72205

Open in the dashboard

General payments

$316

10 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Marny Lemons-Prince of Little Rock, AR is reported in the CMS Open Payments database as having received $316 across 10 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 39th percentile of Dentist, Periodontics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $20 1
2023 General $34 1
2022 General $55 2
2021 General $67 2
2020 General $88 1
2019 General $51 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marny Lemons-Prince
  • Dentist, Periodontics median
  • Middle half of Dentist, Periodontics
  • National median

In program year 2025, general payments to Marny Lemons-Prince were reported at $0. Among 2,732 Dentist, Periodontics profiles paid that year, the median was $112 and the middle half received between $42 and $307.

Show as a table
Year Marny Lemons-Prince Dentist, Periodontics median Middle half National median
2019 $51 $129 $42–$367 $163
2020 $88 $90 $35–$265 $114
2021 $67 $125 $42–$411 $132
2022 $55 $123 $43–$364 $149
2023 $34 $125 $45–$358 $160
2024 $20 $119 $42–$350 $164
2025 $0 $112 $42–$307 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Zimmer Biomet Holdings, Inc. $126 3 payments
  2. Nobel Biocare USA $78 2 payments
  3. Dentsply Sirona Inc $65 3 payments
  4. Straumann USA LLC $47 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $316 10 payments
Products named General payments · program years 2019–2024
  1. Tapered Screw $88 1 payment
  2. NOBELACTIVE $78 2 payments
  3. NOBELPROCERA $44 1 payment
  4. NOBELPARALLEL $44 1 payment
  5. NOBELREPLACE $44 1 payment
  6. NOBELSPEEDY $44 1 payment
  7. Sinus Lift Kits $37 2 payments
  8. ASTRA TECH Implant System $23 1 payment
  9. SYMBIOS $22 1 payment
  10. Consumable Dentistry $20 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

115

Median for Dentist: 47

Drug cost

$721

Median for Dentist: $159

Branded share of claims

17.4%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Fluocinonide Generic 17 $454
Amoxicillin Generic 78 $196
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 20 $70

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Records

10 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Periodontics in Arkansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record